Document Type : Review articles
Authors
1 Chemical Injuries Research Center, Systems Biology and Poisoning Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran
2 Behavioral Sciences Research Center, Lifestyle Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran
3 Department of Biostatistics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
Abstract
Context: The prevalence of in-hospital death due to COVID-19 hospital is one of the qualitative indexes, which can be used to assess the quality of care, as well as the mortality patterns in COVID-19 pandemic.Objectives: Therefore, this study has been done with the goal of estimating overall prevalence in-hospital death due to COVID-19 disease in iranian patients.Evidence Acquisition: Articles were identified through iranian searching databases including Health.barakatkns, IranDoc, SID, Civilica and MagIran and international searching databases including Scopus, Web of Science, PubMed and Elsevier . Additional search was also done by Google Scholar search engine. We reviewed systematically all studies reporting the prevalence of in-hospital death due to COVID-19 disease. In this study meta-analysis method with random effect model has been used to estimate the pooled in-hospital death.Results: 118 records were identified by the electronic search, of which 43 studies were identified as relevant documents that were meta-analyzed for the pooled in-hospital death due to COVID-19 prevalence. Overall, prevalence of death were 12.16% (95% CI: 10.72%-13.61%). The highest and lowest death prevalence has been reported in Northern Provinces (Gilan, 27.27% (95% CI: 8.66%-45.88%) and Mazandaran, 21.27% (95% CI: 18.14%-24.40%)) and Turkish-speaking provinces (Azerbaijan, East, 3.29% (95% CI: 2.11%-4.47%) and Zanjan, 3.42% (95% CI: 1.82%-5.02%)) respectively.Conclusions: Considering the death rate obtained in this study and its comparison with other countries, it can be said that the performance of the Iranian medical system in COVID-19 pandemic is acceptable.
Keywords
- WHO. WHO characterizes COVID-19 as a pandemic. 2020; Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen.
- Grech, V., Unknown unknowns - COVID-19 and potential global mortality. Early human development, 2020. 144: p. 105026-105026.
- WHO. Coronavirus disease (COVID-19) pandemic. 2020 2020-12-01]; Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019?gclid=CjwKCAiA8Jf-BRB-EiwAWDtEGnT5aEuG4ks8f8z7dtHGUcjaM39WLnJ7x3mIhCI7qpdwCot2ITMuOxoCrgkQAvD_BwE.
- Al-Dorzi, H.M., S. Alsolamy, and Y.M. Arabi, Critically ill patients with Middle East respiratory syndrome coronavirus infection. Crit Care, 2016. 20(65): p. 016-1234.
- Tadbiri, H., M. Moradi-Lakeh, and M. Naghavi, All-cause excess mortality and COVID-19-related deaths in Iran. Medical Journal of The Islamic Republic of Iran (MJIRI), 2020. 34(1): p. 561-566.
- Goldstein, N.D. and I. Burstyn, On the importance of early testing even when imperfect in a pandemic such as COVID-19. Global epidemiology, 2020. 2: p. 100031-100031.
- Kandel, N., et al., Health security capacities in the context of COVID-19 outbreak: an analysis of International Health Regulations annual report data from 182 countries. Lancet (London, England), 2020. 395(10229): p. 1047-1053.
- Ding, Z.Y., et al., Association of liver abnormalities with in-hospital mortality in patients with COVID-19. J Hepatol, 2020.
- Yan, X., et al., Neutrophil to lymphocyte ratio as prognostic and predictive factor in patients with coronavirus disease 2019: A retrospective cross-sectional study. J Med Virol, 2020. 92(11): p. 2573-2581.
- Asch, D.A., et al., Variation in US Hospital Mortality Rates for Patients Admitted With COVID-19 During the First 6 Months of the Pandemic. JAMA Intern Med, 2020.
- Goodman, K.E., et al., Impact of Sex and Metabolic Comorbidities on COVID-19 Mortality Risk Across Age Groups: 66,646 Inpatients Across 613 U.S. Hospitals. Clin Infect Dis, 2020.
- Izurieta, H.S., et al., Natural history of COVID-19: Risk factors for hospitalizations and deaths among >26 million U.S. Medicare beneficiaries. J Infect Dis, 2020.
- Mallow, P.J., et al., Outcomes of Hospitalized COVID-19 Patients by Risk Factors: Results from a United States Hospital Claims Database. J Health Econ Outcomes Res, 2020. 7(2): p. 165-174.
- Macedo, M.C.F., et al., Correlation between hospitalized patients' demographics, symptoms, comorbidities, and COVID-19 pandemic in Bahia, Brazil. PLoS One, 2020. 15(12): p. e0243966.
- Núñez-Gil, I.J.J., et al., Underlying heart diseases and acute COVID-19 outcomes. Cardiol J, 2020.
- Rubio-Rivas, M., et al., Predicting Clinical Outcome with Phenotypic Clusters in COVID-19 Pneumonia: An Analysis of 12,066 Hospitalized Patients from the Spanish Registry SEMI-COVID-19. J Clin Med, 2020. 9(11).
- Rodilla, E., et al., Impact of arterial stiffness on all-cause mortality in patients hospitalized with COVID-19 in Spain. Hypertension, 2020.
- Piroth, L., et al., Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study. Lancet Respir Med, 2020.
- Zeitoun, J.D., M. Faron, and J.H. Lefèvre, Impact of the local care environment and social characteristics on aggregated hospital fatality rate from COVID-19 in France: a nationwide observational study. Public Health, 2020. 189: p. 104-109.
- Ferroni, E., et al., Survival of Hospitalized COVID-19 Patients in Northern Italy: A Population-Based Cohort Study by the ITA-COVID-19 Network. Clin Epidemiol, 2020. 12: p. 1337-1346.
- Abate, S.M., Y.A. Checkol, and B. Mantefardo, Global prevalence and determinants of mortality among patients with COVID-19: A systematic review and meta-analysis. Annals of medicine and surgery (2012), 2021. 64: p. 102204-102204.
- Huang, C., et al., Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, 2020. 395(10223): p. 497-506.
- Guo, Y.-R., et al., The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak–an update on the status. Military Medical Research, 2020. 7(1): p. 1-10.
- Shi, H., et al., Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. The Lancet Infectious Diseases, 2020. 20(4): p. 425-434.
- Moher, D., et al., Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev.[Internet]. 2015; 4: 1.
- Chinazzi, M., et al., The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak. Science, 2020. 368(6489): p. 395-400.
- Gostic, K., et al., Estimated effectiveness of symptom and risk screening to prevent the spread of COVID-19. Elife, 2020. 24(9): p. 55570.
- Nicola, M., et al., The socio-economic implications of the coronavirus pandemic (COVID-19): A review. Int J Surg, 2020. 78: p. 185-193.
- Moftakhar, L., et al., Epidemiological characteristics and outcomes of COVID-19 in diabetic versus non-diabetic patients. Int J Diabetes Dev Ctries, 2021. 9: p. 1-6.
- Rastad, H., et al., The risk factors associated with COVID-19-Related death among patients with end‐stage renal disease. Bmc Nephrology, 2021. 22(1).
- Rastad, H., et al., Risk and predictors of in-hospital mortality from COVID-19 in patients with diabetes and cardiovascular disease. Diabetology & Metabolic Syndrome, 2020. 12(1).
- Rastad, H., et al., Factors associated with the poor outcomes in diabetic patients with COVID-19. Journal of Diabetes and Metabolic Disorders, 2020. 19(2): p. 1293-1302.
- Javanian, M., et al., Risk factors for mortality of 557 adult patients with COVID 19 in Babol, Northern Iran: a retrospective cohort study. Bratisl Lek Listy, 2021. 122(1): p. 34-38.
- Javanian, M., et al., Clinical and laboratory findings from patients with COVID-19 pneumonia in Babol North of Iran: a retrospective cohort study. Rom J Intern Med, 2020: p. 161-167.
- Mohammadi, F., et al., Artificial neural network and logistic regression modelling to characterize COVID-19 infected patients in local areas of Iran. Biomedical Journal, 2021.
- Takhti, H.K., et al., Symptoms and factors associated with the hospitalization period of 3480 Covid-19 patients in Hormozgan, Iran. 2021.
- Sami, R., et al., A one-year hospital-based prospective COVID- 19 open-cohort in the Eastern Mediterranean region: The Khorshid COVID Cohort (KCC) study. PLoS One, 2020. 15(11 November).
- Janani, M., et al., Epidemiological features and hotspot of COVID-19 in Isfahan province of Iran: Results of a cohort study. 2020.
- Sayad, B., et al., Leukocytosis and alteration of hemoglobin level in patients with severe COVID‐19: Association of leukocytosis with mortality. Health science reports, 2020. 3(4).
- Moradi, E.V., et al., Increased age, neutrophil-to-lymphocyte ratio (NLR) and white blood cells count are associated with higher COVID-19 mortality. American Journal of Emergency Medicine, 2021. 40: p. 11-14.
- Sobhani, S., et al., Association between Clinical Characteristics and Laboratory Findings with Outcome of Hospitalized COVID-19 Patients: A Report from Northeast Iran. Interdisciplinary perspectives on infectious diseases, 2021. 2021.
- Nasiri, M., et al., The probable association between blood groups and prognosis of covid-19. Iranian Journal of Public Health, 2021. 50(4): p. 825-830.
- Rashidi, F., et al., Incidence of symptomatic venous thromboembolism following hospitalization for coronavirus disease 2019: Prospective results from a multi-center study. Thrombosis Research, 2021. 198: p. 135-138.
- Hormati, A., et al., Clinical characteristics and Mortality risk factors among COVID-19 patients in Qom–Iran; The results of a Retrospective Cohort study. 2020.
- Monfared, A., et al., Clinical characteristics and outcome of COVID-19 pneumonia in kidney transplant recipients in Razi hospital, Rasht, Iran. Transpl Infect Dis, 2020. 22(6): p. 2.
- Araban, M., et al., Epidemiological, clinical characteristics of coronavirus-infected disease (COVID-19) among sample of Iranian community: funding from survey in central of Iran. 2020.
- Peymani, P., et al., Statins in patients with COVID-19: a retrospective cohort study in Iranian COVID-19 patients. Transl Med Commun, 2021. 6(1): p. 021-00082.
- Shahriarirad, R., et al., Epidemiological and clinical features of 2019 novel coronavirus diseases (COVID-19) in the South of Iran. BMC Infectious Diseases, 2020. 20(1): p. 1-12.
- Alamdari, N.M., et al., Mortality risk factors among hospitalized COVID-19 patients in a major referral center in Iran. Tohoku Journal of Experimental Medicine, 2020. 252(1): p. 73-84.
- Baghaei, P., et al., Clinical manifestations of patients with coronavirus disease 2019 (Covid-19) in a referral center in iran. Tanaffos, 2020. 19(2): p. 122-128.
- Bikdeli, B., et al., Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies. Thrombosis Research, 2020. 196: p. 382-394.
- Kashefizadeh, A., et al., Clinical features and short-term outcomes covid-19 in tehran, iran: An analysis of mortality and hospital stay. Acta Biomedica, 2020. 91(4): p. 1-10.
- Pirsalehi, A., et al., Neutrophil-to-lymphocyte ratio (NLR) greater than 6.5 May reflect the progression of COVID-19 towards an unfavorable clinical outcome. Iranian Journal of Microbiology, 2020. 12(5): p. 466-474.
- Sabri, A., et al., Novel coronavirus disease 2019: Predicting prognosis with a computed tomography-based disease severity score and clinical laboratory data. Polish Archives of Internal Medicine, 2020. 130(7-8): p. 629-634.
- Soleimani, A., et al., Effects of Angiotensin Receptor Blockers (ARBs) on In-Hospital Outcomes of Patients With Hypertension and Confirmed or Clinically Suspected COVID-19. American Journal of Hypertension, 2020. 33(12): p. 1102-1111.
- Zali, A., et al., Baseline Characteristics and Associated Factors of Mortality in COVID-19 Patients; an Analysis of 16000 Cases in Tehran, Iran. Arch Acad Emerg Med, 2020. 8(1).
- Homayounieh, F., et al., Clinical and imaging features predict mortality in COVID-19 infection in Iran. PLoS One, 2020. 15(9).
- Maghbooli, Z., et al., Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection. PLoS One, 2020. 15(9 September).
- Looha, M.A., et al., Assessing Sex Differential in COVID-19 Mortality Rate by Age and Polymerase Chain Reaction Test Results; An Iranian Multi-Center Study. 2021.
- Aghaaliakbari, F., et al., Angiotensin Converting Enzyme Inhibitors, A Risk Factor of Poor Outcome in Diabetic Patients with COVID-19 Infection. Iranian journal of kidney diseases, 2020. 14(6).
- Pazoki, M., et al., Risk indicators associated with in-hospital mortality and severity in patients with diabetes mellitus and confirmed or clinically suspected COVID-19. Journal of Diabetes & Metabolic Disorders, 2021: p. 1-11.
- Khoshnood, R.J., et al., Epidemiological Characteristics, Clinical Features, and Outcome of COVID-19 Patients in Northern Tehran, Iran; a Cross-Sectional Study. Advanced Journal of Emergency Medicine, 2020.
- Mousavi, S.A., et al., Hematologic predictors of mortality in hospitalized patients with COVID-19: a comparative study. Hematology, 2020. 25(1): p. 383-388.
- Kalantari, H., A.H.H. Tabrizi, and F. Foroohi, Determination of COVID-19 prevalence with regards to age range of patients referring to the hospitals located in western Tehran, Iran. Gene Reports, 2020. 21: p. 100910.
- Akbariqomi, M., et al., Clinical characteristics and outcome of hospitalized COVID-19 patients with diabetes: A single-center, retrospective study in Iran. diabetes research and clinical practice, 2020. 169: p. 108467.
- Nikpouraghdam, M., et al., Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study. Journal of Clinical Virology, 2020. 127: p. 104378.
- Allameh, S.F., et al., Clinical Characteristics and Outcomes of 905 COVID-19 Patients Admitted to Imam Khomeini Hospital Complex in the Capital City of Tehran, Iran. Archives of Iranian Medicine, 2020. 23(11): p. 766-775.
- Papizadeh, S., et al., Epidemiologic and clinical characteristics of 186 hospitalized patients with Covid-19 in Tehran, Iran: A retrospective, single-center case series. 2020.
- Vahedian-Azimi, A., et al., The Primary Outcomes and Epidemiological and Clinical Features of Coronavirus Disease 2019 (COVID-19) in Iran. Adv Exp Med Biol, 2021: p. 199-210.
- Gharebaghi, N., et al., Evaluation of epidemiology, clinical features, prognosis, diagnosis and treatment outcomes of patients with COVID-19 in West Azerbaijan Province. International Journal of Clinical Practice, 2021: p. e14108.
- Rokni, M., et al., Comparison of clinical, para-clinical and laboratory findings in survived and deceased patients with COVID-19: diagnostic role of inflammatory indications in determining the severity of illness. BMC Infectious Diseases, 2020. 20(1).